Interestingly, this specific variant in SHANK2 corresponds to the R12C alteration in the SHANK3 SPN domain, which has been previously implicated as a potential pathogenic variant in AD patients (Leblond et al., 2014; Sasaki et al., 2020). Here, SHANK3 is linked to Alzheimer disease.